ASX:NXNPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Nexsen Ltd
$0.220
$0.018 (7.37%)
Day Range
$0.220 – $0.260
52 Week Range
$0.130 – $0.345
Volume
569.51K
Avg Volume (10D)
165.16K
Market Cap
$20.41M
Price Chart
Market Statistics
Open$0.240
Previous Close$0.238
Day High$0.260
Day Low$0.220
52 Week High$0.345
52 Week Low$0.130
Valuation
Market Cap20.41M
Shares Outstanding92.77M
Trading Activity
Volume569.51K
Value Traded135.97K
Bid$0.220 × 61,115
Ask$0.225 × 3,319
Performance
1 Day-3.06%
5 Day1.06%
13 Week21.79%
YTD48.44%
Technical Indicators
RSI (14)38.24
50-Day SMA$0.254
200-Day SMA$0.201
Latest News
Biotechnology
Nexsen Secures First Asian Hospital Partner for Diagnostic Commercialisation
Nexsen signs binding term sheet with GHK Hospital to validate and roll out rapid point-of-care diagnostics in North Asia, starting with GBS and kidney tests.
Biotechnology
Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets
Nexsen awarded $1.2m grant to advance StrepSure GBS test in Asia-Pacific; Hong Kong as hub for validation, local manufacturing and near-term commercialization.